Trials / Not Yet Recruiting
Not Yet RecruitingNCT07489131
Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema
A Randomized, Double-masked, Parallel-group, Multicenter Clinical Study to Evaluate the Efficacy and Safety of AVT29 Compared With Eylea HD in Participants With Diabetic Macular Edema
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 256 (estimated)
- Sponsor
- Alvotech Swiss AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Randomized, Double-masked, Parallel-group, Multicenter Clinical Study to Evaluate the Efficacy and Safety of AVT29 Compared with Eylea HD in Participants with Diabetic Macular Edema.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AVT29 (proposed aflibercept HD biosimilar) | Patients will receive IVT injections of AVT29 |
| DRUG | Eylea HD (aflibercept HD) | Patients will receive IVT injections of Eylea HD |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2027-07-01
- Completion
- 2028-01-01
- First posted
- 2026-03-23
- Last updated
- 2026-03-23
Source: ClinicalTrials.gov record NCT07489131. Inclusion in this directory is not an endorsement.